Jazz Pharmaceuticals JAZZ Patent box incentive benefit, amount
Patent box incentive benefit, amount at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept jazz:EffectiveIncomeTaxRateReconciliationPatentBoxIncentiveBenefitAmount.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's patent box incentive benefit, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's patent box incentive benefit, amount?
- Jazz Pharmaceuticals (JAZZ) reported patent box incentive benefit, amount of $15.25M in Q4 2025.
- How has Jazz Pharmaceuticals's patent box incentive benefit, amount changed year-over-year?
- Jazz Pharmaceuticals's patent box incentive benefit, amount decreased by 6.8% year-over-year, from $16.35M to $15.25M.
- What does patent box incentive benefit, amount mean?
- Tax savings achieved by utilizing lower tax rates on income from patented products.
- How do you interpret patent box incentive benefit, amount?
- An increase indicates greater tax efficiency derived from intellectual property holdings.
- How does patent box incentive benefit, amount compare across companies?
- Highly relevant for global pharmaceutical companies; peers in Ireland or similar jurisdictions often report significant benefits here.